维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

1篇 您的检索式：作者名="Sean M.Davidson"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Can glucagon-like peptide-1(GLP-1) analogues make neuroprotection a reality?显示文摘Currently,ischemic stroke remains one of the most costly and devastating clinical syndromes,accounting for 9%of all deaths and being the second leading cause of death in the world(Davidson et al.,2018).Approximately 20%of strokes are caused by intracerebral hemorrhage,while the other^80%are classified as ischemic.With the discovery of thrombolysis,reperfusion therapy became an option for the treatment of ischemic stroke.More recently,endovascular recanalization with mechanical thrombectomy has brought about a paradigm shift in the optimal management of patients with large vessel occlusion.Importantly,early reperfusion is the only therapy that is proven to limit infarct size in patients with acute ischemic stroke.However,despite a successful recanalization being achieved in more than 70% of patients treated with mechanical thrombectomy+/–intravenous tissue recombinant plasminogen activator,functional independence(modified Rankin score 0–2 at 3 months after ischemic stroke)is obtained only in^45% of cases.This reveals the further need to develop new adjunctive neuroprotective treatment strategies alongside reperfusion therapy.	Maryna V.Basalay Sean M.Davidson Derek M.Yellon	2020	Neural Regeneration Research2020，15，10：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费